Respiratory syncytial virus infection in children

Area of Science:

• Pediatrics
• Virology
• Infectious Diseases

Background:

• Respiratory syncytial virus (RSV) is a common cause of pediatric respiratory tract infections, particularly bronchiolitis.
• Most children experience RSV infection by age two, with peak seasons in the Northern Hemisphere from November to April.
• RSV infections are a significant concern for infants and children with underlying health conditions.

Purpose of the Study:

• To provide an overview of respiratory syncytial virus (RSV) infections in children.
• To outline diagnostic criteria, treatment strategies, and prevention methods for RSV.
• To identify risk factors for severe RSV illness and candidates for prophylaxis.

Main Methods:

• Diagnosis relies on clinical presentation, including patient history and physical examination.
• Laboratory tests and chest radiography are generally not required for diagnosis.
• Treatment is primarily supportive, focusing on hydration and oxygenation.

Main Results:

• Typical symptoms include cough, coryza, and wheezing.
• Hospitalization may be necessary for infants under 60 days or those with severe symptoms.
• Antibiotics and corticosteroids are not effective for bronchiolitis; bronchodilators may be used for wheezing.

Conclusions:

• Supportive care is the cornerstone of RSV management.
• Preventative measures like hand washing and palivizumab prophylaxis are crucial for high-risk infants.
• Most children recover fully from RSV infections with appropriate care.